These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

191 related items for PubMed ID: 10079776

  • 1. Potential cost effectiveness of tissue plasminogen activator among patients previously treated with streptokinase.
    Massel D.
    Can J Cardiol; 1999 Feb; 15(2):173-9. PubMed ID: 10079776
    [Abstract] [Full Text] [Related]

  • 2. Cost effectiveness of thrombolytic therapy with tissue plasminogen activator as compared with streptokinase for acute myocardial infarction.
    Mark DB, Hlatky MA, Califf RM, Naylor CD, Lee KL, Armstrong PW, Barbash G, White H, Simoons ML, Nelson CL.
    N Engl J Med; 1995 May 25; 332(21):1418-24. PubMed ID: 7723799
    [Abstract] [Full Text] [Related]

  • 3. Tissue plasminogen activator was cost-effective compared to streptokinase in only selected patients with acute myocardial infarction.
    Kent DM, Vijan S, Hayward RA, Griffith JL, Beshansky JR, Selker HP.
    J Clin Epidemiol; 2004 Aug 25; 57(8):843-52. PubMed ID: 15485737
    [Abstract] [Full Text] [Related]

  • 4. Potential cost effectiveness of intravenous tissue plasminogen activator versus streptokinase for acute myocardial infarction.
    Goel V, Naylor CD.
    Can J Cardiol; 1992 Aug 25; 8(1):31-8. PubMed ID: 1617509
    [Abstract] [Full Text] [Related]

  • 5. Patient reperfusion preferences in acute myocardial infarction: mortality versus stroke, benefits versus costs, high technology versus drugs.
    Tsui W, Pierre K, Massel D.
    Can J Cardiol; 2005 Apr 25; 21(5):423-31. PubMed ID: 15861260
    [Abstract] [Full Text] [Related]

  • 6. [Evaluation of the cost-effectiveness of thrombolytic therapy in acute myocardial infarct using tissue plasminogen activator or streptokinase:the Italian perspective].
    Lorenzoni R, Fattore G, Gensini G.
    G Ital Cardiol; 1997 Jul 25; 27(7):721-6. PubMed ID: 9303862
    [Abstract] [Full Text] [Related]

  • 7. Fibrin-specific thrombolytic agents.
    Collen D.
    Schweiz Med Wochenschr; 1987 Nov 14; 117(46):1791-8. PubMed ID: 3122317
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Long-term mortality of patients with acute myocardial infarction in the United States and Canada: comparison of patients enrolled in Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries (GUSTO)-I.
    Kaul P, Armstrong PW, Chang WC, Naylor CD, Granger CB, Lee KL, Peterson ED, Califf RM, Topol EJ, Mark DB.
    Circulation; 2004 Sep 28; 110(13):1754-60. PubMed ID: 15381645
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Is the use of t-PA as compared with streptokinase cost effective?
    Rose EA.
    N Engl J Med; 1995 Oct 12; 333(15):1009; author reply 1010. PubMed ID: 7666904
    [No Abstract] [Full Text] [Related]

  • 14. [The absence of a procoagulant effect after TNK-t-PA: a comparison with streptokinase and rt-PA].
    De Marco E, Andreotti F, van de Greef W, Quaranta G, Biasucci LM, Kol A, Maseri A, Rebuzzi AG.
    Cardiologia; 1998 Nov 12; 43(11):1209-13. PubMed ID: 9922587
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Tissue-type plasminogen activator (t-PA): comments on results of the GISSI-2 study].
    Turazza FM.
    Medicina (Firenze); 1990 Nov 12; 10(2):193-4. PubMed ID: 2125681
    [Abstract] [Full Text] [Related]

  • 17. Pitfalls in the economic evaluation of thrombolysis in myocardial infarction. The impact of national differences in the cost of thrombolytics and of differences in the efficacy across patient subgroups.
    Lorenzoni R, Pagano D, Mazzotta G, Rosen SD, Fattore G, De Caterina R, Gensini G.
    Eur Heart J; 1998 Oct 12; 19(10):1518-24. PubMed ID: 9820990
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Tissue-type plasminogen activator].
    Turazza FM, Pogna M.
    Medicina (Firenze); 1990 Oct 12; 10(1):75-8. PubMed ID: 2116566
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.